Five things for pharma marketers to know: Wednesday, July 18, 2018

Novartis voluntarily halts price increases; Shkreli's former company considers name change; FDA issues guidance to modernize electronic health data in trials.

from Most popular articles from Medical Marketing and Media https://ift.tt/2JAAFaD